Refinement of estimates of mortality risk using the Radiologic Severity Index in hematologic malignancy patients with respiratory syncytial virus infection.
Ajay SheshadriMahtab KarimipourErik VakilLara BashouraMyrna GodoyMuhammad H ArainScott E EvansBurton F DickeyDavid E OstRoy F ChemalySaadia A FaizPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2019)
Although baseline immunodeficiency in HM patients helps predict 60-day mortality after RSV LRTI, mortality risk estimates can be further refined by also measuring LRTI progression using RSI. RSI is well-suited as a marker of LRTI severity in RSV infection.